MatthewHoMDPhD

PubMed

• Longitudinal genetically detectable minimal residual disease by fluorescencehybridization confers a poor prognosis in myeloma.
  Cui, J., Yu, T., Lv, R., Liu, J., Fan, H., Yan, W., Xu, J., Du, C., Deng, S., Sui, W., Xu, Y., Anderson, K., Dong, X., Qiu, L., An, G., Ho, M.> ;Therapeutic Advances in Medical Oncology. 2024 Jan 1
• Chimeric antigen receptor T-cell therapy in hematologic malignancies: Successes, challenges, and opportunities.
  Matthew Ho, Saurabh Zanwar, Jonas Paludo> ;European Journal of Haematology. 2024 Feb 1
• 6 citations
  Natural history, predictors of development of extramedullary disease, and treatment outcomes for patients with extramedullary multiple myeloma.
  Saurabh Zanwar, Matthew Ho, Yi Lin, Prashant Kapoor, Moritz Binder, Francis K Buadi, Angela Dispenzieri, David Dingli, Amie Fonder, Morie A Gertz, Wilson Gonsalves, Su...> ;American Journal of Hematology. 2023 Oct 1
• An atlas of the bone marrow bone proteome in patients with dysproteinemias.
  Matthew Ho, Surendra Dasari, Alissa Visram, Matthew T Drake, M Cristine Charlesworth, Kenneth L Johnson, Ganesh P Pujari, Dragan Jevremovic, Taxiarchis Kourelis> ;Blood Cancer Journal. 2023 Apr 28
• The burden of myeloma: novel approaches to disease assessment.
  Matthew Ho, Taxiarchis Kourelis> ;Hematology. American Society of Hematology. Education Program. 2022 Dec 9
• Hiding in Plain Sight.
  Jwan A Naser, Delvise Fogwe, Matthew Ho, Cristina Corsini Campioli, Aditya Shah> ;The New England Journal of Medicine. 2022 Dec 1
• Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.
  Saurabh Zanwar, Matthew Ho, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Raf...> ;Blood Cancer Journal. 2022 Nov 24
• 11 citations
  Treating Multiple Myeloma in the Context of the Bone Marrow Microenvironment.
  Matthew Ho, Alexander Xiao, Dongni Yi, Saurabh Zanwar, Giada Bianchi> ;Current Oncology. 2022 Nov 21
• 2 citations
  Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance.
  Matthew Ho, Saurabh Zanwar, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Raf...> ;Blood. 2022 Nov 3
• 15 citations
  Risk factors for severe infection and mortality In patients with COVID-19 in patients with multiple myeloma and AL amyloidosis.
  Matthew Ho, Saurabh Zanwar, Francis K Buadi, Sikander Ailawadhi, Jeremy Larsen, Leif Bergsagel, Moritz Binder, Asher Chanan-Khan, David Dingli, Angela Dispenzieri, Raf...> ;American Journal of Hematology. 2023 Jan 1
• 1 citations
  A Rare Complication: Postoperative Pyoderma Gangrenosum in Segmental Colitis Associated With Diverticulosis.
  Katie Dunleavy, Delvise Fogwe, Gerard Forde, Matthew Ho, Jacob Stewart, Molly Youssef, William Perry, Darrell Pardi> ;The American Journal of Gastroenterology. 2022 Nov 1
• A 44-year-old man with esophageal ulcer.
  Delvise T Fogwe, Matthew T Ho, Aditya S Shah> ;Clinical Case Reports. 2022 Jul 1
• 2 citations
  Risk factors for the development of orthostatic hypotension during autologous stem cell transplant in patients with multiple myeloma.
  Matthew Ho, Maria Moscvin, Soon Khai Low, Benjamin Evans, Sara Close, Robert Schlossman, Jacob Laubach, Claudia Paba Prada, Brett Glotzbecker, Paul G Richardson, Giada...> ;Leukemia & Lymphoma. 2022 Oct 1
• Erratum: Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China: Err...
  Zhongqing Zou, Tingting Guo, Jian Cui, Wenjiao Tang, Yan Li, Fangfang Wang, Tian Dong, Yunfan Yang, Yan Feng, Matthew Ho, Li Zhang, Ling Pan, Ting Niu> ;Journal of Cancer. 2022 Jan 1
• 6 citations
  Overcoming drug resistance by targeting protein homeostasis in multiple myeloma
  Maria Moscvin, Matthew Ho, Giada Bianchi> ;Cancer Drug Resistance. 2021 Dec 2
• 44-Year-Old Man With Anemia, Thrombocytopenia, and Acute Kidney Injury.
  Sauraubh Zanwar, Morie A. Gertz> ;Mayo Clinic Proceedings. 2021 Nov 30
• Hiding in (Not So) Plain Sight: Spontaneous Tumor Lysis Syndrome due to Intravascular Large B Cell Lymphoma
  Saurabh Zanwar, Patrick Duggan, Ryan M. Carr, Thomas M. Habermann, Patrick J. Navin, Mohamed E. Salama, Sameer A. Parikh> ;American Journal of Hematology. 2021 Oct 22
• 13 citations
  Multiple Myeloma Cells Depend on the DDI2/NRF1-mediated Proteasome Stress Response for Survival
  Tianzeng Chen, Jenna Briere, Maria Moscvin, Peter G. Czarnecki, Kenneth C. Anderson, T. Keith Blackwell, Giada Bianchi> ;Blood Advances. 2021 Oct 14
• 11 citations
  Outcomes of triple class (proteasome inhibitor, IMiDs and monoclonal antibody) refractory patients with multiple myeloma.
  , , , , , , , , , , , , , , , , , , > ;Leukemia. 2021 Oct 11
• 9 citations
  The Effect of Duration of Lenalidomide Maintenance and Outcomes of Different Salvage Regimens in Patients with Multiple Myeloma (MM).
  , , , , , , , , , , , , , , , , , > ;Blood Cancer Journal. 2021 Sep 22
• 7 citations
  YWHAE/14-3-3ε expression impacts the protein load, contributing to proteasome inhibitor sensitivity in multiple myeloma.
  , , , , , , , , , , , , , , , , , , , , , , , > ;Blood. 2019 Oct 1
• 5 citations
  Real-world data combined with studies on Regulatory B Cells for newly diagnosed Multiple Myeloma from a tertiary referral Hospital in South-Western China.
  Zhongqing Zou, Tingting Guo, Jian Cui, Wenjiao Tang, Yan Li, Fangfang Wang, Tian Dong, Yunfan Yang, Yan Feng, Matthew Ho, Li Zhang, Ling Pan, Ting Niu> ;Journal of Cancer. 2021 Mar 5
• 35 citations
  Changing paradigms in diagnosis and treatment of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM).
  Ashish Patel, Chia Yin Goh, Maria Moscvin, Li Zhang, Giada Bianchi> ;Leukemia. 2020 Oct 12
• Role of the Bone Marrow Milieu in Multiple Myeloma Progression and Therapeutic Resistance.
  Ho M, Goh CY, Patel A, Staunton S, O'Connor R, Godeau M, Bianchi G> ;Clinical lymphoma, myeloma & leukemia. 2020-06-07
• 7 citations
  Primary Plasma Cell Leukemia: Real-World Retrospective Study of 46 Patients From a Single-Center Study in China.
  Tengteng Yu, Yan Xu, Gang An, Zengjun Li, Shuhui Deng, Dehui Zou, Zhen Yu, Mu Hao, Kenneth C. Anderson, Lugui Qiu, > ;Clinical Lymphoma, Myeloma & Leukemia. 2020 Oct 1
• Join now to see all

Journal Articles

• Targeting Protein Synthesis and Degradation in Multiple Myeloma  
  Ho M, Bianchi G, American Journal of Hematology and Oncology
• Exploiting Autophagy in Multiple Myeloma  
  Ho M, Patel A, Hanley C, Murphy A, McSweeney T, Zhang L, McCann A, O’Gorman P, Bianchi G, Journal of Cancer Metastasis and Treatment
• ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment  
  Bianchi G, Czarnecki PG, Ho M, Roccaro AM, Sacco A, Kawano Y, Gulla A, Samur AA, Chen T, Wen K, Tai YT, Moscvin M, Wu X, Camci-Unal G, Claudio, M, Bolli N, Sewastianik..., Blood Cancer Discovery
• Proteomics inspired precision medicine for treating and understanding multiple myeloma  
  Ho M, Bianchi G, & Anderson KC, Expert Review of Precision Medicine and Drug Development 2020, 2/20/2020
• Join now to see all